A combination of stereological methods, biochemistry and electron microscopy for the investigation of drug treatment effects in experimental animals

J Microsc. 2016 Mar;261(3):267-76. doi: 10.1111/jmi.12329. Epub 2015 Oct 20.

Abstract

Some chemotherapeutic agents used for breast cancer (BC) treatment can induce severe side effects in the ovarian tissue. The combination of cyclophosphamide and docetaxel (TC) is widely used for BC treatment; however, its late effects in the ovary are not completely understood. The main purpose of this study was to evaluate the structural and ultrastructural alterations in the ovarian stroma induced by TC treatment. Wistar rats were divided into two groups: a control group and a TC group. They were euthanized 5 months after the end of treatment, and their plasma and ovaries were collected. Important alterations were noted. The serum estradiol level was significantly reduced in the TC group compared with the control group. Additionally, the number of apoptotic nuclei was higher in the TC group. The role of the inflammatory response in the development of ovarian damage was investigated, and we found an increased number of mast cells and increased expression of TNF-α in the TC group. The involvement of fibrosis was also investigated. The results showed that the TC group had increased expression levels of TGF-β1, collagen type I (col-I) and collagen type III (col-III) compared with the control group. Ultrastructural analysis revealed the presence of collagen fibrils in the treated group and illustrated that the ovarian tissue architecture was more disorganized in this group than in the control group. The results from this study are important in the study of chemotherapy-induced ovarian failure and provide further insight into the mechanisms involved in the development of this disease.

Keywords: Breast cancer; CIOF; cyclophosphamide; docetaxel; ovarian fibrosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Apoptosis / drug effects*
  • Collagen Type I / metabolism
  • Collagen Type III / metabolism
  • Cyclophosphamide / adverse effects*
  • Cyclophosphamide / therapeutic use
  • Docetaxel
  • Estradiol / blood
  • Female
  • Mammary Neoplasms, Animal / drug therapy*
  • Microscopy, Electron, Transmission
  • Ovary / drug effects*
  • Ovary / ultrastructure*
  • Rats
  • Rats, Wistar
  • Taxoids / adverse effects*
  • Taxoids / therapeutic use
  • Transforming Growth Factor beta1 / metabolism
  • Uterus / drug effects*

Substances

  • Antineoplastic Agents
  • Collagen Type I
  • Collagen Type III
  • Taxoids
  • Transforming Growth Factor beta1
  • Docetaxel
  • Estradiol
  • Cyclophosphamide